for May 10, 2023 through May 16, 2023
🆕️⚡️⚡️Retrospective, single-center, quasi-experimental study @OFIDJournal
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 11, 2023
Clindamycin plus Vancomycin versus Linezolid for Treatment of Necrotizing Soft Tissue Infection
Cc @JonathanRyderMD @Cortes_Penfield https://t.co/HlR7NcXq9Y pic.twitter.com/WW2GFzRQN8
🆕️⚡️ @antibioticsmdpi@AlbertoEMaraolo
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 15, 2023
Stenotrophomonas maltophilia Infections: A Systematic Review and Meta-Analysis of Comparative Efficacy of Available Treatments, with Critical Assessment of Novel Therapeutic Options
Can you believe no single RCT😲😲https://t.co/ChIpzQpVRF
#AACJournal launches a new section focused on antimicrobial stewardship led by editors @ryankshields and @pranita_tamma . We are seeking for high quality papers that advance the field if antimicrobial stewardship @ASMicrobiology @asm_tmc https://t.co/G34Fy38xSL
— Cesar Arias (@SuperBugDoc) May 15, 2023
Excellent 🆕️⚡️⚡️Narrative Review @CMIJournal @miriam_knoll
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 13, 2023
How to use direct microscopy for diagnosing fungal infections #IDTwitter
Cc @DrNeilStone @FungalDochttps://t.co/STtVH7MzAW pic.twitter.com/IT0fH1ouNs
Researchers used deep learning models to identify filamentous fungi encountered in the clinical lab, highlighting the potential of merging advanced technology with medical lab practices for accurate & efficient diagnosis of fungi. @JournalSpectrum: https://t.co/WmovzmuuEa pic.twitter.com/TH7IC7fuVg
— ASM (@ASMicrobiology) May 16, 2023
bursting with pride for Josh, stellar pharmacy resident, & Viv + Peyton, 2 amazing students (now pharmacists!) who collaborated on implementing this change + collecting the data over 3+ years.
— Erin McCreary (@ErinMcCreary) May 12, 2023
Clinda/Vanc vs Linezolid for NSTI in @OFIDJournalhttps://t.co/l0e5KVuSSd
🔥 ATTACK RCT 🔥 @TheLancetInfDis
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 11, 2023
fficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex #IDTwitter https://t.co/MRUNXUuFZI
Wow., it's published! @BradSpellberg et al @CMIJournal
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 11, 2023
🔥Choosing Patients Over Placebos: Oral Transitional Therapy vs. IV-Only Therapy for Bacteremia and Infective Endocarditis🔥 #IDTwitter https://t.co/JSYPYnK64E
ImmunoProfile is an at-home test kit that measures antibody titers for 11 infectious diseases. Titers may be necessary to forgo vaccination requirements for certain industries.
— Children’s Health Defense (@ChildrensHD) May 16, 2023
Would you try this?#TheDefenderhttps://t.co/8D6oyyF1ro
WATCH: Dr. Didier Raoult is a French specialist in infectious diseases and professor of microbiology. He spoke to the NCI about hydroxychloroquine, which he has promoted as a cure for COVID-19, vaccine efficacy, and censorship.https://t.co/R8s3PxHRzW
— Rebel News (@RebelNewsOnline) May 15, 2023
💊📣New in @OFIDJournal : a retrospective comparison of clindamycin + vancomycin vs linezolid for necrotizing soft tissue infection; composite outcome of death, AKI or C. difficile more common in clindamycin + vancomycin group #IDTwitter https://t.co/fPCwjrq8Cp pic.twitter.com/NiT7N861eO
— SIDP (@SIDPharm) May 12, 2023
🆕️🔥🔥 Review @CMIJournal @ParhamSendi @Cortes_Penfield
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 12, 2023
Prof .Ilker Uçkay
Early switch from IV to oral antibiotic treatment in bone & joint infections
A strict minimum duration of IV treatment (minimal threshold) for BJIs is not supported by data https://t.co/N5RnSxg9NC pic.twitter.com/3BPGHqkn0K
🌟ISAC/APUA/ESCMID Consensus statement🌟
— International Society of Antimicrobial Chemotherap (@ischemo) May 15, 2023
The battle against fungi:lessons in antifungal stewardship from COVID-19 times
We are pleased to publish this article on behalf of ISAC/APUA/ESCMID #AntimicrobialStewardship & Fungal Infection Study Groups in #IJAAhttps://t.co/4Hev3gT5X5 pic.twitter.com/X4kf00i3Uv
🔥🔥Just published 🔥🔥@iwgdf / @IDSAInfo 2023
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 15, 2023
Guidelines on the diagnosis and treatment of foot infection in persons with diabetes
Check 🌟table 5🌟 similar to our OM @Wiki_Guidelines recomm #shorterisbetter theme is prevailing! #IDTwitter https://t.co/56LRsdEiam#IDTwitter pic.twitter.com/DWN99CJLcP
🆕️⚡️⚡️Retrospective observational, propensity score-matched study
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 11, 2023
ACCEPT—UTI @jac_amr
No significant difference in clinical success for patients treated empirically with pip/tazo compared with carbapenems for ESBL UTIs incl c.cystitis & pyelonephritishttps://t.co/2tl4ej5h3w
Fungal infections:
— MicrobesInfect (@MicrobesInfect) May 14, 2023
Pathogenesis, antifungals and alternate treatment approacheshttps://t.co/JMcmzsu0EA #OpenAccess #biofilm pic.twitter.com/sKfFuOzcZu
Originally ineffective against carbapenem-resistant Enterobacteriaceae, the antibiotic linezolid exhibits excellent antibacterial and antibiofilm activity when used in combination with pentamidine, an antifungal/antiprotozoal agent. @JournalSpecturm: https://t.co/iWFeWdxk02 pic.twitter.com/yrmtCxyVBE
— ASM (@ASMicrobiology) May 12, 2023
WATCH: Dr. Didier Raoult is a French specialist in infectious diseases and professor of microbiology. He spoke to the NCI about hydroxychloroquine, which he has promoted as a cure for COVID-19, vaccine efficacy, and censorship.https://t.co/ICx2nzuJCT
— Rebel News Canada (@RebelNews_CA) May 15, 2023
The virus isn’t gone in the US either, just the data.
— Laura Miers (@LauraMiers) May 16, 2023
“The number of COVID-19 infections reported in Beijing has overtaken the city's influenza cases since late April, ranking in first place among all the 16 kinds of notifiable infectious diseases.” https://t.co/8TQct5YGLP
Penicillin-Susceptible Streptococcus pneumoniae Meningitis in Adults: Does the Ceftriaxone Dosing Matter? #IDTwitter @ParhamSendihttps://t.co/vOhjbfPe9I
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 14, 2023
Hugely informative review on implementation science in #antibioticstewardship scholarly work
— ASP_MirandaS PharmD MPH (@ASP_MirandaS) May 12, 2023
from .@JulieSzymczak .@ASPphysician and a stellar 🤩panel of experts:https://t.co/VBQiVCqyRo
Getting at least one dose of a COVID vaccine lowers the risk of developing long COVID, suggests a study published online Dec. 6, 2022, by the journal Antimicrobial Stewardship & Healthcare Epidemiology.https://t.co/EkhprLHIIi
— I'm baaaaaccck! :) (@DECO22155891) May 16, 2023
WATCH: Dr. Didier Raoult is a French specialist in infectious diseases and professor of microbiology. He spoke to the NCI about hydroxychloroquine, which he has promoted as a cure for COVID-19, vaccine efficacy, and censorship.https://t.co/v3noIfKzLC
— Rebel News Québec (@RebelNews_QC) May 15, 2023
.@PharmerMeg showing the benefits of “cefazolin for all” at @MAD_ID_ASP
— Erin McCreary (@ErinMcCreary) May 12, 2023
⬇️ infections without an ⬆️ in hypersensitivity when cefazolin used over clinda or vanc perioperatively in patients with reported pcn allergies https://t.co/xdxMWlGp0c pic.twitter.com/H4bR3OMNQC
Zinc is an essential mineral. Its long been known for its beneficial effects on immune health. On top of regulating immune function, zinc also aids in fighting infectious diseases like the flu and pneumonia. This is my favorite liquid zinc supplement: https://t.co/aisKBo5KZ1 #ad pic.twitter.com/l8hEwqN9BL
— esotericbot (@esotericbot) May 15, 2023
🆕️⚡️Single-center, retrospective, quasi-experimental study
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 15, 2023
Clinical utility of MRSA nasal PCR to streamline antimicrobial use in treatment of diabetic foot infection with or without osteomyelitis #IDTwitter https://t.co/vDvMoQCN2e
🆕️⚡️Small Propensity Score-Matched Analysis #AAC
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 16, 2023
In pts treated for beta-hemolytic streptococcal BSI, those who transitioned to oral antibiotics by day 7 showed higher rates of 30-d treatment failure than propensity-matched pts @BradSpellberg @DrToddLeehttps://t.co/eXx045jPKG
🆕️⚡️⚡️Quality improvement study indicated that an urgent care antibiotic stewardship initiative was associated with decreased antibiotic prescribing for respiratory conditions. This study provides a model for UC antibiotic stewardship #IDTwitter https://t.co/ckgLThdRC9
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 11, 2023
The battle against fungi - lessons in antifungal stewardship from COVID-19 times: a consensus statement on behalf of the ISAC, APUA, ESCMID Study Group for Antimicrobial Stewardship, and ESCMID Fungal Infection Study Group
— Alexander V. Veselov 😷💊🎮☮️ (@DrAlexxx78) May 14, 2023
Souha S. Kanj, et al.https://t.co/JVI4HTesFY
🆕️⚡️Systematic review & meta-analysis #JAC
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 12, 2023
9 RCTs ~ 30K
In a predominantly immunized population of COVID-19 outpatients, molnupiravir has no effect on mortality, probably none on ‘hospitalization or death’ and effects on symptom resolution are uncertain https://t.co/9CxFYZDDlk
Perspectives of Statistician, Microbiologist, and Clinician Stakeholders on the Use of Microbiological Outcomes in Randomised Trials of Antimicrobial Stewardship Interventions https://t.co/4531Pos17v #mdpiantibiotics via @antibioticsmdpi
— Kerry Hood is working 100% for 50% pay (@kerryhood) May 10, 2023
The latest from Byron Hyde MD. Dr Hyde's historical knowledge of ME is unparalleled and I strongly urge new students of chronic post-infectious diseases to read his work. #MyalgicEncephalomyelitishttps://t.co/H9ERRkNvh3
— Dan Wyke 🦠➡️🧠🔥 (@Dan_Wyke) May 16, 2023
#AntibioticResistance in pets is increasing due, in part, to overuse of #antibiotics. Reduced antibiotic effectiveness is a threat to the long-term health of our pets #AntibioticStewardship. Read more from @CIDRAP at: https://t.co/aXhb3CveMk #NationalPetWeek pic.twitter.com/6s21s0mNQQ
— iAMR (@i_AMResponsible) May 11, 2023
If left unchecked, #AMR could upend Canada’s health system by 2050, resulting in nearly 400,000 deaths & $120 billion in hospital costs. This new @CanadaAMR video shows how #Canada can incentivize antimicrobial innovation & stewardship to better prepare https://t.co/AJL0w4Gi6I pic.twitter.com/VARbef47oL
— AMR Action Fund (@AMRActionFund) May 10, 2023
Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use #IDTwitter https://t.co/UFQvZWbfsr
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 14, 2023
🤩 Inspiring work from *then* PGY1 @NikkiTranID and *then* P4 @vivianytsai on their work on extended infusion beta lactams and clinda vs linezolid for NSTI, respectively #MADID2023 https://t.co/aftZQRLCpfhttps://t.co/AkAfJZ5VW6 pic.twitter.com/SS7u5o6WgD
— David Ha (@DHpharmd) May 13, 2023
Europe notes increase in NDM-5 E coli, an expanding #superbug
— CIDRAP (@CIDRAP) May 12, 2023
Scientists spotlight an increase in E coli isolates carrying the blaNDM-5 gene that makes them resistant to carbapenems, a key class of antibioticshttps://t.co/8L0ACEprBP#AMR #AntibioticStewardship pic.twitter.com/dfOXeUgOJr
New research: Sulbactam–durlobactam versus colistin for the treatment of serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)https://t.co/JyrrRhxUEf
— The Lancet Infectious Diseases (@TheLancetInfDis) May 12, 2023
📉 Participating in NHSN AU module?
— David Ha (@DHpharmd) May 11, 2023
⚒️New QI tool from @CDCgov: Targeted Assessment for ABX Stewardship (TAS)
🎯 Provides specific target for ABX reduction based on SAAR: AU-Cumulative Attributable Difference (AU-CAD)#MADID2023https://t.co/sSiuC0OGSX pic.twitter.com/dfoSg84Jm4
9 of 10 #LongCOVID patients in study report slow recovery over 2 years
— CIDRAP (@CIDRAP) May 15, 2023
A total of 4.9% said their symptoms were resolving quickly, and 4.3% said they had multiple symptoms that varied little over timehttps://t.co/EODaMNzO0g#COVID19 pic.twitter.com/4e1zV5UFeM
Here they are, fully explicated and updated -- Types of HIV Papers.
— Paul Sax (@PaulSaxMD) May 16, 2023
Note the following:
- @xkcdComic is brilliant
- shout outs to @SeretIDirini and @DrJLi
- a truly great video from @emmerpope, who's probably wondering what she's doing in an ID bloghttps://t.co/E0O2GZ52V1
In this placebo-controlled RCT, ART intensification with DTV +/- MVC did not improve HIV-related cognitive impairment.
— Paul Sax (@PaulSaxMD) May 15, 2023
Note also that DTG did not lead to increased weight -- an important result given concerns about INSTIs causing increased weight.https://t.co/iMWpeCrqoU
Wastewater surveillance in airports is a new tool for monitoring the spread of infectious diseases. By analyzing sewage samples, we can detect potential outbreaks and take timely action to protect public health. #publichealth #wastewatersurveillance https://t.co/EhQYpqwdCN
— Dylan George (@dylanbgeorge) May 10, 2023
New consensus statement from @ischemo, @APUANews, and the @ESCMID antimicrobial stewardship and fungal infection study groups:
— CIDRAP-ASP (@CIDRAP_ASP) May 15, 2023
"The battle against fungi—lessons in antifungal stewardship from COVID-19 times" https://t.co/8SDYxiFVfA
⚡️Which trial do we need?⚡️ @CMIJournal
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 12, 2023
Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients
TMP-SMX monotherapy vs. combination therapy (TMP-SMX plus echinocandin) #IDTwitter https://t.co/r32xHHrV7v
#MicrobiologyMonday: Microbiome analyses of sugarcane juices & biofilms from raw sugar factories suggest diverse microbes are involved in sugarcane juice degradation; the results may inform strategies to inhibit the process. Sweet! @JournalSpectrum: https://t.co/CF2qxQkPTe pic.twitter.com/e0nEvMZd0o
— ASM (@ASMicrobiology) May 15, 2023
🆕️⚡️#JAC
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) May 16, 2023
Multicentre, retrospective audit of "oral" fosfomycin use for urinary tract infections in Australian children and adolescents #IDTwitter https://t.co/RjmAHBOSjB
My first ever first-author paper is now available in @CDCgov Emerging Infectious Diseases journal!!!
— Grace Tyson (@immunoloGT) May 11, 2023
Link here: https://t.co/7F3LsX9cwg
We tested samples from over 2000 cats and found that SARS-CoV-2 seroprevalence in the UK feline population is over 3%.
Thread Below...🧵
Prevalence of antimicrobial resistance in urine, blood, and wound pathogens among rural patients in Karnataka, India #stewardship #antimicrobialresistancehttps://t.co/tFwZvjir9q pic.twitter.com/qhzre2TYfl
— ASHE Journal (@ASHE_Journal) May 16, 2023
Study found evidence that viruses infecting microbes in the deep sea interact with a far more diverse set of hosts than previously thought.
— MicrobesInfect (@MicrobesInfect) May 11, 2023
On paper: Viruses interact with hosts that span distantly related microbial domains in dense hydrothermal matshttps://t.co/OgAiMEA3a1 pic.twitter.com/ugcu4YRy1m
Trajectories of evolution of post COVID19 condition,upto 2yr after symptoms onset-International Journal Infectious Diseases. 91% with post COVID19 improve slowly~2yr course; 5% improved rapidly; 4% persistent condition; Trajectories asso:character/symptom https://t.co/432OHTMmJq
— Prof. Dr. Sanjeev Bagai (@BagaiDr) May 16, 2023
Created by Cameron Forbes. Last updated May 24, 2023 at 05:16 EST.